Unknown

Dataset Information

0

Extracellular ATP reduces tumor sphere growth and cancer stem cell population in glioblastoma cells.


ABSTRACT: Glioblastoma is the most aggressive tumor in the CNS and is characterized by having a cancer stem cell (CSC) subpopulation essential for tumor survival. The purinergic system plays an important role in glioma growth, since adenosine triphosphate (ATP) can induce proliferation of glioma cells, and alteration in extracellular ATP degradation by the use of exogenous nucleotidases dramatically alters the size of gliomas in rats. The aim of this work was to characterize the effect of the purinergic system on glioma CSCs. Human U87 glioma cultures presented tumor spheres that express the markers of glioma cancer stem cells CD133, Oct-4, and Nanog. Messenger RNA of several purinergic receptors were differently expressed in spheres when compared to a cell monolayer not containing spheres. Treatment of human gliomas U87 or U343 as well as rat C6 gliomas with 100 ?M of ATP reduced the number of tumor spheres when grown in neural stem cell medium supplemented with epidermal growth factor and basic fibroblast growth factor. Moreover, ATP caused a decline in the number of spheres observed in culture in a dose-dependent manner. ATP also reduces the expression of Nanog, as determined by flow cytometry, as well as CD133 and Oct-4, as analyzed by flow cytometry and RT-PCR in U87 cells. The differential expression of purinergic receptor in tumor spheres when compared to adherent cells and the effect of ATP in reducing tumor spheres suggest that the purinergic system affects CSC biology and that ATP may be a potential agonist for differentiation therapy.

SUBMITTER: Ledur PF 

PROVIDER: S-EPMC3286536 | BioStudies | 2012-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2009-01-01 | S-EPMC2655289 | BioStudies
2020-01-01 | S-EPMC7554888 | BioStudies
1000-01-01 | S-EPMC4467125 | BioStudies
1000-01-01 | S-EPMC3734134 | BioStudies
2011-01-01 | S-EPMC3094354 | BioStudies
2016-01-01 | S-EPMC5082736 | BioStudies
2008-01-01 | S-EPMC2739001 | BioStudies
1000-01-01 | S-EPMC3578492 | BioStudies
2016-01-01 | S-EPMC5173151 | BioStudies
2016-01-01 | S-EPMC4826802 | BioStudies